Medicaid spending for Pathology and Laboratory Procedures in Beverly Hills climbs to $5,476,737 in 2024

Dr. Mehmet Oz CMS Administrator
Dr. Mehmet Oz CMS Administrator
0Comments

Providers in Beverly Hills submitted Medicaid claims totaling $5,476,737 for services under the Pathology and Laboratory Procedures category in 2024, data from the U.S. Department of Health and Human Services Medicaid Provider Spending database shows. This represents a 56.9% increase compared with 2023, when $3,490,420 was billed for similar services.

Medicaid is a public insurance program managed by each state and financed in partnership by federal and state governments. The program covers low-income residents, families, children, seniors, and people with disabilities, making it a significant component of the U.S. health system.

Given that Medicaid is taxpayer funded, shifts in billing at the local level indicate how public health spending is distributed in a community.

The “Pathology and Laboratory Procedures” service group represents a range of Medicaid-billed services defined by the nature of care, organized by standardized HCPCS and CPT code sets. Billing codes were categorized using consistent numerical prefixes and ranges for this analysis, which allowed for grouping similar services without overlap and tracking accurate rankings over time.

While total Medicaid spending increased in multiple areas, Pathology and Laboratory Procedures was the second-highest category for Medicaid payments in Beverly Hills in 2024.

Looking statewide, this category placed fifth in total Medicaid payments in California for 2024.

Across the five years up to 2024, payments connected to Pathology and Laboratory Procedures in Beverly Hills rose by $5,413,909, a jump of 8617%. Some years saw accelerated growth, especially in 2023 and 2022.

Although spending for Pathology and Laboratory Procedures occurred throughout Beverly Hills, the payments were most significant in a few ZIP codes. In 2024, the ZIP codes with the largest Medicaid payments in this category were 90211 at $3,566,952, 90210 totaling $1,907,648, and 90212 with $2,136. These 3 ZIP codes comprised 100% of total Medicaid spending in this category for the city that year.

Most Medicaid payments in the Pathology and Laboratory Procedures group focused on a small subset of billing codes.

For further context, while Medicaid payments in the Pathology and Laboratory Procedures category jumped by 56.9% between 2024 and 2023 in Beverly Hills, Medicaid payments across all claim categories citywide increased by 25.5% over the same period.

Centers for Medicare & Medicaid Services data shows that federal and state Medicaid spending together totaled roughly $871.7 billion in fiscal year 2023, making up about 18% of all national health expenditures. This marks a notable increase from $613.5 billion in 2019, before the COVID-19 pandemic began.

This growth amounts to nearly 40% over several years, with key drivers including higher enrollment numbers and increased service use during and following the pandemic period.

Recent federal budget measures under the Trump administration have featured proposals aimed at reducing federal Medicaid funding and changing the program’s structure. The “One Big Beautiful Bill Act,” which became law in 2025, is expected to result in federal Medicaid cuts of over $1 trillion over the next decade. The law also introduces work requirements and higher cost-sharing, which could reduce benefits and funding for specific groups of recipients. These policy shifts are likely to place more of the funding burden on states and slow the growth of federal contributions, even as Medicaid enrollment remains substantial.

Medicaid Payments Tied to Pathology and Laboratory Procedures in Beverly Hills, California Over Five Years

Year Total Medicaid Payments % Change From Previous Year
2020 $62,828 -81%
2021 $113,111 80%
2022 $472,138 317.4%
2023 $3,490,419 639.3%
2024 $5,476,737 56.9%
Top Categories by Medicaid Payments in Beverly Hills, California, 2024

Rank Category Medicaid Payments Share of City Total
1 Evaluation and Management $5,521,511 24.5%
2 Pathology and Laboratory Procedures $5,476,737 24.3%
3 Medicine Services and Procedures $5,365,825 23.8%
4 Temporary National Codes (Non-Medicare) $3,039,436 13.5%
5 Surgery $2,121,003 9.4%
6 Anesthesia $312,290 1.4%
7 Dental Services $232,830 1%
8 Radiology Procedures $195,541 0.9%
9 Orthotic Procedures and services $144,290 0.6%
10 Ambulance and Other Transport Services and Supplies $77,413 0.3%
11 Temporary Codes $23,047 0.1%
12 Procedures / Professional Services $19,078 0.1%
13 Medical And Surgical Supplies $13,123 0.1%
14 Administrative, Miscellaneous and Investigational $9,671 <0.1%
15 Drugs Administered Other than Oral Method $6,663 <0.1%
16 Chemotherapy Drugs $797 <0.1%
Top 20 HCPCS Codes Within the Pathology and Laboratory Procedures Category in Beverly Hills, California, 2024

HCPCS Code Description Medicaid Payments Claims
87635 Sars-cov-2 covid-19 amp prb $2,114,867 17
87811 Sars-cov-2 covid19 w/optic $1,856,836 24
87502 Influenza dna amp probe $469,791 12
87634 Rsv dna/rna amp probe $390,951 12
87428 Sarscov & inf vir a&b ag ia $253,951 23
87651 Strep a dna amp probe $220,394 12
87633 Resp virus 12-25 targets $58,245 8
87804 Influenza assay w/optic $48,345 7
80053 Comprehen metabolic panel $17,710 65
85025 Complete cbc w/auto diff wbc $12,907 77
87798 Detect agent nos dna amp $8,070 7
87426 Sarscov coronavirus ag ia $6,317 2
87486 Chlmyd pneum dna amp probe $5,741 8
87581 M.pneumon dna amp probe $5,741 8
80305 Drug test prsmv dir opt obs $2,108 9
84075 Assay alkaline phosphatase $867 10
82310 Assay of calcium $561 10
88305 Tissue exam by pathologist $303 11
82306 Vitamin d 25 hydroxy $283 9
83970 Assay of parathormone $249 6

Note: HCPCS codes are shown for context within the category. Category totals and rankings in this article are based on standardized service groupings rather than individual billing codes.

Information in this article was obtained from the U.S. Department of Health and Human Services Medicaid Provider Spending database. The source data can be found here.



Related

Grace Graham, Deputy Commissioner for Policy, Legislation, and International Affairs of FDA

Nicholas McAndrew, M.D. facility in Santa Monica reviewed by FDA for bioresearch monitoring on Feb. 6

The FDA conducted a bioresearch monitoring inspection at Nicholas McAndrew, M.D. in Santa Monica on Feb. 6, according to federal data.

Melanie Keller, Deputy Commissioner for Operations and Chief Operating Officer of FDA

Moldex-Metric, Inc. in Culver City reviewed by FDA for device compliance March 5

The FDA conducted a device compliance and post-market assurance inspection at Moldex-Metric, Inc. in Culver City on March 5, as noted in data from the agency’s website.

Benjamin D. Moncarz Chief Financial Officer - FDA

FDA issues 2 citations to Moldex-Metric, Inc. following March 5 inspection in Culver City

The FDA cited Moldex-Metric, Inc. in Culver City on March 5 after an inspection focused on device compliance and postmarket assurance. The company received 2 citations, FDA data shows.

Trending

The Weekly Newsletter

Sign-up for the Weekly Newsletter from West LA Times.